The number of people living with some form of dementia is expected to double in the next 25 years, and while for some it's in their genes, for others, the disease may be influenced by lifestyle.

The recent NFOs are mostly open-ended, allowing investors the flexibility to buy or sell shares at the fund's current NAV, ...

Keros Therapeutics advances KER-065 toward DMD trials, trims costs, and extends its cash runway as investors weigh it against ...

Despite effective suppression of viral replication by antiretroviral therapy (ART), chronic HIV infection remains characterized by persistent low-level inflammation and progressive tissue damage, ...

Apple has officially released the first beta of iOS 26.3, providing users and developers with an early look at the latest features, performance upgrades, and regulatory compliance updates. This beta ...

A team led by scientists at King's College London, in collaboration with national and international partners, has discovered how a specific group of immune cells in the gut—Group 3 Innate Lymphoid ...

Research dating back to 1972 has persistently found that low-volatility (or low beta) stocks have systematically provided higher risk-adjusted returns than high-risk stocks. Today, many leading equity ...